Pilot study of low-molecular-weight heparin in the treatment of acute ischemic stroke.
Author(s) -
R. Kay,
Ka Sing Wong,
Jean Woo
Publication year - 1994
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.25.3.684
Subject(s) - medicine , low molecular weight heparin , heparin , stroke (engine) , placebo , adverse effect , acute stroke , anesthesia , ischemic stroke , surgery , clinical trial , ischemia , alternative medicine , tissue plasminogen activator , pathology , mechanical engineering , engineering
Our purpose was to assess the feasibility and risk of performing a double-blind placebo-controlled study of low-molecular-weight heparin in the treatment of acute ischemic stroke.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom